Cure My Disease

Don't miss your cure!

 Log in / Sign up

Targeted radiation may extend life for patients with limited bone metastases

NCT ID NCT03143322

Ongoing Disease control Sponsor: UNICANCER Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding a high-precision type of radiation called SBRT to usual cancer treatments (like hormone therapy or chemo) can delay cancer growth in people with breast, lung, or prostate cancer that has spread to 1 to 5 bones. About 168 adults aged 18-75 with good overall health are taking part. The goal is to see if the extra radiation improves how long the cancer stays under control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm lung neoplasm metastatic carcinoma in the bone metastatic malignant neoplasm metastatic prostate carcinoma non-small cell lung carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE METASTASES METASTATIC BREAST CANCER METASTATIC LUNG CANCER METASTATIC PROSTATE CANCER

Contacts and locations

Locations

  • Centre Amethyst CROM

    Creil, France

  • Centre Catalan D'Oncologie

    Perpignan, France

  • Centre Henri Becquerel

    Rouen, France

  • Centre Léon Bérard

    Lyon, France

  • Centre Léonard de Vinci

    Dechy, France

  • Centre Marie Curie

    Arras, France

  • Centre Oscar Lambret

    Lille, France

  • Centre Pierre Curie

    Beuvry, France

  • Centre d'oncologie et radiothérapie Saint-Jean

    Saint-Doulchard, France

  • Centre de Cancérologie du Grand Montpellier

    Montpellier, France

  • Chu Grenoble

    Grenoble, France

  • Clinique Ambroise Pare

    Beuvry, France

  • Clinique Tivoli Ducos

    Bordeaux, France

  • Clinique des dentellières

    Valenciennes, France

  • GCS RISSA - Institut de cancérologie Paris Nord

    Sarcelles, France

  • Hôpital Henri Mondor

    Créteil, France

  • Hôpital Métropole Savoie

    Chambéry, France

  • Hôpital Privé Le Bois

    Lille, France

  • Hôpital Privé Les Bonnettes

    Arras, France

  • ICO - Site Paul Papin

    Angers, France

  • Institut Bergonié

    Bordeaux, France

  • Institut Jean Godinot

    Reims, France

  • Institut Paoli Calmettes

    Marseille, France

  • Institut Sainte Catherine

    Avignon, France

  • Institut de Cancérologie de Bourgogne

    Dijon, France

  • Institut de Cancérologie de Lorraine

    Nancy, France

  • Institut de Cancérologie de l'Ouest

    Nantes, France

  • Pôle Leonard de Vinci

    Chambray-lès-Tours, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.